{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:24:55Z","timestamp":1793805895580,"version":"4.6.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118552","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:03:23Z","timestamp":1792227803000},"page":"118552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P4","title":["Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma"],"prefix":"10.1016","volume":"254","author":[{"given":"Kecheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3669-0336","authenticated-orcid":false,"given":"Tianxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118552_b0005","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central nervous System Tumors Diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0010","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in patients with Recurrent Glioblastoma: the CheckMate 143 phase 3 Randomized Clinical Trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0020","first-page":"22","article-title":"Molecular Mechanisms of Treatment Resistance in Glioblastoma","author":"Ou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118552_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118552_b0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118552_b0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.abn7570","article-title":"Mechanism-based design of agents that selectively target drug-resistant glioma","volume":"377","author":"Lin","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bcp.2026.118552_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy."},{"key":"10.1016\/j.bcp.2026.118552_b0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12951-022-01479-6","article-title":"Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma","volume":"20","author":"Zhuang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.118552_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/dmd.112.048322","article-title":"Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma","volume":"41","author":"Agarwal","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2026.118552_b0055","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1158\/0008-5472.CAN-18-0569","article-title":"Replication stress Drives Constitutive Activation of the DNA damage Response and Radioresistance in Glioblastoma Stem-like Cells","volume":"78","author":"Carruthers","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133289","article-title":"In Vitro and In Vivo Drug-Response Profiling using Patient-Derived High-Grade Glioma","volume":"15","author":"Rajan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118552_b0065","first-page":"117","article-title":"DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal","volume":"233","author":"Ludlum","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bcp.2026.118552_b0070","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1535-7163.MCT-16-0176","article-title":"Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating drugs","volume":"15","author":"Berte","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118552_b0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11033-024-09247-5","article-title":"CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine","volume":"51","author":"Wang","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2026.118552_b0080","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, Recognition, and Processing of Cisplatin-DNA Adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau4972","article-title":"Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118552_b0090","first-page":"2050","article-title":"Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-\u03baB-dependent pathway","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2026.118552_b0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10571-020-00873-8","article-title":"[Pt(O,O'-acac)(\u03b3-acac)(DMS)]: Alternative strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells","volume":"41","author":"Astesana","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118552_b0100","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.1416418112","article-title":"Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins","volume":"112","author":"Poruchynsky","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118552_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007965","article-title":"Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles","volume":"6","author":"Zasadil","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118552_b0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jmb.2017.01.001","article-title":"Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures","volume":"429","author":"Kellogg","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41580-018-0009-y","article-title":"Microtubule dynamics: an interplay of biochemistry and mechanics","volume":"19","author":"Brouhard","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/34465","article-title":"Structure of the alpha beta tubulin dimer by electron crystallography","volume":"391","author":"Nogales","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118552_b0125","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2026.118552_b0130","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118552_b0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jconrel.2020.04.028","article-title":"Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy","volume":"323","author":"Graham-Gurysh","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118552_b0140","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1158\/1078-0432.CCR-21-2563","article-title":"Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma","volume":"28","author":"Dmello","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0145","first-page":"22","article-title":"Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma","author":"Cornelison","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118552_b0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-cellbio-101011-155711","article-title":"Microtubules in cell migration","volume":"29","author":"Etienne-Manneville","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0160","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1101\/gad.432107","article-title":"Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation","volume":"21","author":"Bermejo","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2026.118552_b0165","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1158\/0008-5472.CAN-09-4295","article-title":"PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors","volume":"70","author":"McEllin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0170","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/0008-5472.CAN-18-2439","article-title":"Replication stress: an Achilles' Heel of Glioma Cancer Stem-like Cells","volume":"78","author":"Morgan","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0175","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/1535370215590819","article-title":"Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model","volume":"240","author":"Vejjasilpa","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bcp.2026.118552_b0180","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-019-0497-x","article-title":"Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module","volume":"22","author":"Munji","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2026.118552_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2026.118552_b0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.200302070","article-title":"Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice","volume":"161","author":"Nitta","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(82)91227-6","article-title":"Electrical resistance of brain microvascular endothelium","volume":"241","author":"Crone","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2026.118552_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/mi12040441","article-title":"Review of Design Considerations for Brain-on-a-Chip Models","volume":"12","author":"Cameron","year":"2021","journal-title":"Micromachines"},{"key":"10.1016\/j.bcp.2026.118552_b0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jm00180a022","article-title":"Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability","volume":"23","author":"Levin","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118552_b0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics."},{"key":"10.1016\/j.bcp.2026.118552_b0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(24)00476-9","article-title":"Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease","volume":"24","author":"Pedder","year":"2025","journal-title":"The Lancet Neurology."},{"key":"10.1016\/j.bcp.2026.118552_b0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer's risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118552_b0225","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2026.118552_b0230","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","article-title":"P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan","volume":"13","author":"de Vries","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0235","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12918-017-0498-x","article-title":"A computational study of the inhibition mechanisms of P-glycoprotein mediated paclitaxel efflux by kinase inhibitors","volume":"11","author":"Bender","year":"2017","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0240","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bcp.2026.118552_b0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-8118-10-12","article-title":"The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects","volume":"10","author":"de Lange","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.bcp.2026.118552_b0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118552_b0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? a critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-016-0004","article-title":"Solid stress and elastic energy as measures of tumour mechanopathology","volume":"1","author":"Nia","year":"2016","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bcp.2026.118552_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100549","article-title":"The scrambled story between hyaluronan and glioblastoma","volume":"296","author":"Pibuel","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118552_b0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fbioe.2019.00341","article-title":"The Extracellular Matrix and Biocompatible Materials in Glioblastoma Treatment","volume":"7","author":"Belousov","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bcp.2026.118552_b0275","doi-asserted-by":"crossref","unstructured":"Boucher Y, Salehi H, Witwer B, Harsh GRt, Jain RK. Interstitial fluid pressure in intracranial tumours in patients and in rodents. British journal of cancer. 1997; 75: 829-36.","DOI":"10.1038\/bjc.1997.148"},{"key":"10.1016\/j.bcp.2026.118552_b0280","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/10717544.2019.1639844","article-title":"Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery","volume":"26","author":"Zhan","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2026.118552_b0285","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","article-title":"Reengineering the Physical Microenvironment of Tumors to Improve Drug delivery and Efficacy: from Mathematical Modeling to Bench to Bedside","volume":"4","author":"Stylianopoulos","year":"2018","journal-title":"Trends in Cancer."},{"key":"10.1016\/j.bcp.2026.118552_b0290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.118552_b0295","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306973121","article-title":"Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy","volume":"121","author":"Kudruk","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118552_b0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118552_b0305","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/thno.26869","article-title":"State-of-the-art of microbubble-assisted blood-brain barrier disruption","volume":"8","author":"Song","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118552_b0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118552_b0315","article-title":"Submicron-bubble-enhanced focused ultrasound for blood-brain barrier disruption and improved CNS drug delivery","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118552_b0320","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0325","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ultrasmedbio.2007.10.016","article-title":"Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index","volume":"34","author":"McDannold","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0330","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ultrasmedbio.2004.04.010","article-title":"Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles","volume":"30","author":"Sheikov","year":"2004","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300291120","article-title":"The mechanosensitive ion channel Piezo1 contributes to ultrasound neuromodulation","volume":"120","author":"Zhu","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118552_b0340","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","article-title":"Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium","volume":"34","author":"Sheikov","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.bcp.2026.118552_b0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12951-021-01137-3","article-title":"Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7","volume":"19","author":"Zuo","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.118552_b0350","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12031-011-9629-9","article-title":"The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles","volume":"46","author":"Deng","year":"2012","journal-title":"Journal of Molecular Neuroscience : MN."},{"key":"10.1016\/j.bcp.2026.118552_b0355","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1073\/pnas.1614777114","article-title":"Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation","volume":"114","author":"Kovacs","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118552_b0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption using Focused Ultrasound and Microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118552_b0365","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","article-title":"Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier","volume":"324","author":"Todd","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118552_b0370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0375","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","article-title":"Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in patients with Recurrent Glioblastoma","volume":"25","author":"Idbaih","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0380","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharma.2024.09.002","article-title":"In vivo pharmacokinetic study of carmustine in rats after giving single-dose of carmustine API solution, flexible liposomes, in situ nasal gel, optimized flexible liposomes embedded in situ nasal gel, and marketed formulation","volume":"83","author":"Mali","year":"2025","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.bcp.2026.118552_b0385","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1080\/1061186X.2025.2526713","article-title":"Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment","volume":"33","author":"Wang","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bcp.2026.118552_b0390","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.2147\/IJN.S167142","article-title":"Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2026.118552_b0395","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0400","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.7150\/thno.37128","article-title":"On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118552_b0405","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118552_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39972","article-title":"Bi-modal confirmation of liposome delivery to the brain after focused ultrasound-induced blood-brain barrier opening","volume":"10","author":"Payne","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.118552_b0415","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bcp.2026.118552_b0420","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/IJN.S158696","article-title":"Stimuli-responsive polymeric micelles for drug delivery and cancer therapy","volume":"13","author":"Zhou","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2026.118552_b0425","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.addr.2012.01.020","article-title":"Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications","volume":"64","author":"Fleige","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0430","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1002\/anie.200250653","article-title":"Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change","volume":"42","author":"Bae","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bcp.2026.118552_b0435","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2026.118552_b0440","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.7150\/thno.34883","article-title":"Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118552_b0445","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","article-title":"Ultrasound-mediated delivery of Paclitaxel for Glioma: a Comparative Study of distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0555","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/107327489800500204","article-title":"Implantable Slow-Release Chemotherapeutic Polymers for the Treatment of Malignant Brain Tumors","volume":"5","author":"Sampath","year":"1998","journal-title":"Cancer Control : Journal of the Moffitt Cancer Center."},{"key":"10.1016\/j.bcp.2026.118552_b0560","doi-asserted-by":"crossref","DOI":"10.1227\/neu.0000000000002817","article-title":"Efficacy and Safety of Carmustine Wafer Implantation after Ventricular opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in adults","author":"Roux","year":"2024","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bcp.2026.118552_b0565","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/acsabm.3c00688","article-title":"Functionalized Carbon Nano-Onions as a Smart Drug delivery System for the Poorly Soluble Drug Carmustine for the Management of Glioblastoma","volume":"7","author":"Majumder","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bcp.2026.118552_b0570","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002800050588","article-title":"Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors","volume":"39","author":"Sipos","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118552_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107415","article-title":"A novel microbubble delivery platform with high payload of paclitaxel upon focused ultrasound for enhanced glioblastoma treatment","volume":"217","author":"Yan","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2026.118552_b0580","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118552_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123730","article-title":"Dual-responsive nanoparticle system for enhanced blood-brain barrier crossing and glioblastoma penetration","volume":"327","author":"Zheng","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118552_b0590","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.molpharmaceut.9b01215","article-title":"Nose-to-Brain delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma","volume":"17","author":"Ullah","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2026.118552_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113711","article-title":"Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma","volume":"382","author":"Kim","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118552_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110985","article-title":"Anti-glioma effect of paclitaxel mediated by specific mode electroacupuncture stimulation and the related role of the Hedgehog pathway","volume":"213","author":"Ma","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2026.118552_b0605","doi-asserted-by":"crossref","DOI":"10.2196\/84593","article-title":"Clinical Efficacy and Safety Assessment of Specific-Mode Electroacupuncture Stimulation combined with Paclitaxel for Recurrent Malignant Gliomas: Study Protocol for a Single-arm Trial","volume":"15","author":"Jia","year":"2026","journal-title":"JMIR Research Protocols."},{"key":"10.1016\/j.bcp.2026.118552_b0610","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118552_b0545","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-024-04904-y","article-title":"A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma","volume":"172","author":"Narsinh","year":"2025","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2026.118552_b0615","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173008","article-title":"Local delivery of Irinotecan to Recurrent GBM patients at Reoperation Offers a Safe Route of Administration","volume":"16","author":"McConville","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118552_b0620","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1007\/s13346-024-01524-x","article-title":"Local administration of irinotecan using an implantable drug delivery device stops high-grade glioma tumor recurrence in a glioblastoma tumor model","volume":"14","author":"Abdelnabi","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bcp.2026.118552_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213102","article-title":"Enhanced delivery to brain using sonosensitive liposome and microbubble with focused ultrasound","volume":"141","author":"Moon","year":"2022","journal-title":"Biomaterials Advances."},{"key":"10.1016\/j.bcp.2026.118552_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18060907","article-title":"Limitations of Gliadel Wafers and strategies for Next-Generation local delivery Systems for Glioblastoma","volume":"18","author":"Kartal","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118552_b0455","series-title":"Baril P","first-page":"18","author":"Priya Dharshini","year":"2026"},{"key":"10.1016\/j.bcp.2026.118552_b0460","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/jacs.4c16898","article-title":"Convection-Enhanced delivery of Auristatin-Conjugated Layer-by-Layer Nanoparticles for Glioblastoma Treatment","volume":"147","author":"Pickering","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2026.118552_b0465","doi-asserted-by":"crossref","unstructured":"Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet (London, England). 1995; 345: 1008-12.","DOI":"10.1016\/S0140-6736(95)90755-6"},{"key":"10.1016\/j.bcp.2026.118552_b0470","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0142-9612(02)00170-9","article-title":"Why degradable polymers undergo surface erosion or bulk erosion","volume":"23","author":"von Burkersroda","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118552_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/polym14142963","article-title":"Polymeric Nanoparticles in Brain Cancer Therapy: a Review of Current Approaches","volume":"14","author":"Caraway","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.bcp.2026.118552_b0480","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in brain extracellular space","volume":"88","author":"Sykov\u00e1","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1676691","article-title":"An implantable, intracerebral osmotic pump for convection-enhanced drug delivery in glioblastoma multiforme","volume":"15","author":"Berlet","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0490","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballest\u00edn","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118552_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010003","article-title":"Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme-an In Vivo Safety, Persistence, and Efficacy Study","volume":"17","author":"King","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118552_b0505","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1021\/acsnano.6c03253","article-title":"Injectable Trojan Horse Hydrogel Unleashing Penetrable and Immunostimulatory Nanomicelles for Postoperative Treatment of Glioblastoma","volume":"20","author":"Zhang","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2026.118552_b0510","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijpharm.2018.07.033","article-title":"Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival","volume":"548","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2026.118552_b0515","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-023-04552-8","article-title":"Adjuvant convection-enhanced delivery for the treatment of brain tumors","volume":"166","author":"Kreatsoulas","year":"2024","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2026.118552_b0520","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s13346-020-00773-w","article-title":"Convection-enhanced delivery of liposomal drugs for effective treatment of glioblastoma multiforme","volume":"10","author":"Han","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bcp.2026.118552_b0525","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S1470-2045(22)00626-X","article-title":"Chronic convection-enhanced intratumoural delivery of chemotherapy for glioblastoma","volume":"23","author":"Young","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0530","article-title":"Breaking Barriers: Advancements in CNS Drug delivery for Glioblastoma. Medical sciences (Basel","volume":"14","author":"Al Fidawi","year":"2026","journal-title":"Switzerland)"},{"key":"10.1016\/j.bcp.2026.118552_b0535","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3171\/2009.11.JNS091052","article-title":"Poor drug distribution as a possible explanation for the results of the PRECISE trial","volume":"113","author":"Sampson","year":"2010","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bcp.2026.118552_b0540","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","article-title":"Convection-Enhanced delivery","volume":"14","author":"Mehta","year":"2017","journal-title":"Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics."},{"key":"10.1016\/j.bcp.2026.118552_b0550","doi-asserted-by":"crossref","unstructured":"Rolfe NW, Dadario NB, Canoll P, Bruce JN. A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma. Pharmaceuticals (Basel, Switzerland). 2024; 17.","DOI":"10.3390\/ph17080973"},{"key":"10.1016\/j.bcp.2026.118552_b0630","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200241060-00002","article-title":"Pharmacokinetics of the carmustine implant","volume":"41","author":"Fleming","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2026.118552_b0635","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2147\/PPA.S93020","article-title":"Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy","volume":"10","author":"Kleinberg","year":"2016","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.bcp.2026.118552_b0640","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11910-015-0611-8","article-title":"Nitrosoureas in the Management of Malignant Gliomas","volume":"16","author":"Brandes","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bcp.2026.118552_b0645","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2003","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0650","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118552_b0655","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1097-0142(20010115)91:2<417::AID-CNCR1016>3.0.CO;2-9","article-title":"A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a north American Brain Tumor Consortium report","volume":"91","author":"Chang","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2026.118552_b0660","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1507940","article-title":"Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma","volume":"15","author":"Holman","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0665","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1039\/D5CS00440C","article-title":"Biomimetic liposomes in drug delivery: from design mechanisms to applications","volume":"55","author":"Li","year":"2026","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2026.118552_b0670","first-page":"27","article-title":"Advancements in Drug delivery Systems in Glioblastoma Therapy","author":"Mishra","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118552_b0675","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/neuonc\/nov104","article-title":"Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma","volume":"17","author":"Field","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0680","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-011-0722-2","article-title":"Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab na\u00efve, recurrent glioblastoma","volume":"107","author":"Reardon","year":"2012","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2026.118552_b0685","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0000000000000990","article-title":"Unveiling the enigma of the blood-brain barrier in glioblastoma: current advances from preclinical and clinical studies","volume":"35","author":"Ahmed","year":"2023","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0690","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3389\/fonc.2019.00966","article-title":"Convection-Enhanced delivery: connection to and Impact of Interstitial Fluid Flow","volume":"9","author":"Stine","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0695","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2026.118552_b0700","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1158\/1535-7163.MCT-16-0788","article-title":"Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas","volume":"16","author":"King","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118552_b0705","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bcp.2026.118552_b0710","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118552_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102424","article-title":"RIP2\/NF-\u03baB\/PD-L1 signaling pathway is involved in temozolomide resistance by inducing autophagy in glioblastoma cells","volume":"58","author":"Liu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2026.118552_b0720","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2026.118552_b0725","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1158\/0008-5472.CAN-12-2838","article-title":"Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism","volume":"73","author":"Munson","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118552_b0730","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:25:01Z","timestamp":1793802301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":146,"alternative-id":["S0006295226008956"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118552","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118552"}}